B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PPP1CC

MOLECULAR TARGET

protein phosphatase 1 catalytic subunit gamma

UniProt: P36873NCBI Gene: 55015 compounds

PPP1CC (protein phosphatase 1 catalytic subunit gamma) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PPP1CC

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1demethyl cantharidin3.3026
2cantharidin3.1823
3microcystin lr2.5612
4calyculin a2.208
5Okadaic Acid2.087

About PPP1CC as a Drug Target

PPP1CC (protein phosphatase 1 catalytic subunit gamma) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented PPP1CC interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PPP1CC inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.